ONCYFA
Live / Registered — Registered (as of 19 Dec 2023)
What this means for you
Registered since 19 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97826069
- Registration number
- 7249313
- Mark type
- Stylized text
- Filed
- 07 Mar 2023
- Published for opposition
- 03 Oct 2023
- Registered
- 19 Dec 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone
Owner
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
Prosecution history
- 19 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Oct 2023 — PUBLISHED FOR OPPOSITION
- 13 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2023 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 21 Aug 2023 — ASSIGNED TO EXAMINER
- 08 Jun 2023 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 27 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Mar 2023 — NEW APPLICATION ENTERED